OR WAIT null SECS
March 03, 2021
AstraZeneca has announced that the mass rollout of its COVID-19 vaccine has begun via the COVAX initiative.
Oxular has raised US $37 million in a financing round led by specialist life sciences investor, Forbion.
Arcline Investment Management has acquired ChargePoint Technology, strengthening its global presence.
A recent survey by SwedenBIO has demonstrated a major upswing in the Swedish life science industry.
EMA has recommended that Evrysdi be granted marketing authorization in the EU for the treatment of patients with certain types of SMA.
RDIF has announced that the Sputnik V vaccine for COVID-19 has been approved in Slovakia under the emergency use authorization procedure.
The EC has launched a structured dialogue aimed at gaining a better understanding of global medicines supply chains and to identify potential causes and drivers of vulnerabilities.
March 02, 2021
Reviews of FDA initiatives and activities recapitulate efforts to assess and approve new drugs, generic drugs, and biologics and strategies for advancing new initiatives.
FDA moves recommended timeline for API and drug manufacturers to assess impurity risks to March 31, 2021.
Under the terms of the acquisition, OXGENE will become a fully owned subsidiary of WuXi Advanced Therapies, WuXi AppTec’s cell and gene therapy contract testing, development, and manufacturing organization business unit.